Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PORTAL 1: Insulin Glulisine in Type 1 Diabetes
NCT00964574Phase 4Completed
- Sponsor
- Sanofi
- Start
- Jul 2009
- Primary completion
- Jul 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin glulisine in type 1 diabetes mellitus (T1D), sponsored by Sanofi. Started Jul 2009; status: completed.
02
Drugs
insulin glulisine
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00964574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00964574.